VascularStrategies LLC is your premier scientific partner for drug and therapeutic development. As a trusted contract research organization, they specialize in supporting pharmaceutical and biotech companies in preclinical and Phase I-IV studies of drug development. With a focus on novel functional endpoints, VascularStrategies utilizes assays to reverse atherosclerosis and advance cardiovascular disease therapies.

Renowned for their expertise, flexibility, and outstanding client services, VascularStrategies offers a range of research services to both large and small pharmaceutical and biotech companies. They provide GMP, GLP, and GCLP compliant research services, as well as early stage research and development. Their impressive repertoire includes a growing list of validated biomarker assays, coupled with a network of scientific and technology expertise.

This allows VascularStrategies to deliver efficient and cost-effective research services, ultimately helping their clients bring cardiovascular disease therapies to market swiftly. Contact VascularStrategies LLC today to benefit from their industry-leading research capabilities and drive innovation in drug development